Orna Therapeutics

Heading to @ESGCT? Catch Orna’s Dan Egan presenting on in vivo hematopoietic stem cell gene editing approach for the treatment of beta-hemoglobinopathies during Poster Session 1. Discover how we’re pioneering safe, effective in vivo therapies. ornatx.com/orna-therapeut… #ESGCT2024

Recently Orna collaborated with @SCFG to donate laptops for its free programs empowering young minds to explore #STEM and connect with inspiring mentors. We’re proud to contribute to building a brighter, equitable future for girls in science. Learn more: youtube.com/watch?v=K6oACR…

This Thursday, Orna CSO Robert Mabry will be speaking at the 9th Annual @CAR_TCell Summit. Join us as we share data on circular RNA therapy for the treatment of B cell malignancies, and a panel discussion highlighting the potential for the next generation of in vivo #celltherapy.

We’re thrilled to welcome Nobel Laureate Carolyn Bertozzi to our SAB as Co-Chair. Dr. Bertozzi’s expertise as a pioneer in emerging technologies will be invaluable as we advance a new category of panCAR™ in vivo CAR #RNA medicines. #Biotech #Science ornatx.com/orna-therapeut…

Orna’s acquisition of @ReNAgadeTx is a testament to our dedication to revolutionizing healthcare by unlocking a new and class of RNA-based medicines. With our combined technologies, we can expand R&D to address the unmet needs of countless rare diseases! ornatx.com/orna-therapeut…

Orna has acquired @ReNAgadeTx — a significant step forward for the field of #RNA-targeted therapies. We are leveraging deep knowledge and a range of highly innovative capabilities to solve the most pressing challenges in drug development today. Read more: ornatx.com/orna-therapeut…

Orna is Baltimore-bound! Be sure to catch us at #ASGCT2024, where we’ll present several posters highlighting our industry-leading circular RNA technology (oRNA). For more info: annualmeeting.asgct.org

🎧 Listen to the full conversation on your favorite podcast platform or on the website here: bioprocessonline.com/solution/the-b…

Thank you @mattpillar and @AnnaRoseWelch for a great Business of Biotech conversation with our CEO Tom Barnes, covering the journey of an academic in biotech and the immense potential of circles in #RNA!

Catch our Associate Director of Delivery Sciences, Kevin Kauffman, at the MIT Research and Development Conference this week! He’ll be discussing RNA engineering, #celltherapy development and Orna being ahead of the curve - register today: ilp.mit.edu/RD23

The weather may be cooling down but we’re continuing to keep things hot 🔥 We’re thrilled to be recognized as a 2023 honoree of the BostInno Fire Awards in the Biotech category, and proud to be part of the Boston innovation ecosystem.  bizjournals.com/boston/inno/st…

Congratulations to Orna Founder and Board Member Daniel G. Anderson, PhD, on his election to the 2023 Class of @theNAMedicine in recognition of his work pioneering the area of non-viral #GeneTherapy and cellular delivery.

Orna CSO Robert Mabry shared how we are using circular RNA for the next generation of CARs in the Immuno-Oncology 360 Summer 2023 newsletter. Read more here! theconferenceforum.org/io-newsletters/ #IO360

Orna is Four(na)! 🎉 We celebrated our 4th anniversary at 500 Forge this week and no birthday party is complete without some ice cream. Cheers to another year and to this talented team: we're looking forward to what's to come!

Happy #Pride from Team Orna! Emily Fitzgerald, Senior Research Associate and other Ornacorns shared some rainbow bagels at the office to celebrate. Thank you to @mamalehs for providing these yummy treats! 🌈

Attending the Accelerating Bio-Innovation 2023 Conference on June 20th in Cambridge? CEO Tom Barnes will speak about next-generation genetic therapies with Harvard's David Liu, Korro Bio's Ram Aiyar, and MPM BioImpact Capital's Christiana Bardon.

CEO Tom Barnes joined our friends at Notch Therapeutics and AvenCell Therapeutics at the #WMIF2023 for "A Deep Dive on Cell Therapy: Applying Lessons Learned from First-Generation Cell Therapies." Watch the replay: youtube.com/watch?v=uu8s2d…

Congratulations to our joint venture partner @ReNAgadeTx on this exciting milestone. Here's to continued success in our collaboration! #DrugDevelopment #biotech

#ICYMI - last week Orna proudly presented data demonstrating the continued progression of our oRNAplatform and lead program ORN-101 at #PEGS23 & #ASGCT23. View the presentations at bit.ly/3okNLTS

Orna is excited to unveil data demonstrating progress of our oRNA platform and improvements in lead program ORN-101 at @PEGSBoston & @ASGCTherapy this week: prn.to/42OiN5t #PEGS23 #ASGCT23